Jiansheng Wan
Fortuna: 93 M $ al 31/08/2026
Fortuna: 93 M $ al 31/08/2026
Jiansheng Wan worked at Sinotherapeutics, Inc. from 2012 to 2025, serving as Director from 2023 to 2025.
Dr. Wan earned a doctorate from the University of Southern California in 1991.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 30/04/2026 | 67.800.932 ( 14,96 % ) | 93 M $ | 31/08/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
| SINOTHERAPEUTICS INC. | Director Ejecutivo | 01/04/2023 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 2 |
|---|---|
University of Southern California
University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sinotherapeutics, Inc.
Sinotherapeutics, Inc. BiotechnologyHealth Technology Engages in R&D, innovation and pharmaceutical preparation of medicines | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.